LOVANIA_NURSERIES_LIMITED - Accounts


Company Registration No. 03921428 (England and Wales)
LOVANIA NURSERIES LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020
LOVANIA NURSERIES LIMITED
COMPANY INFORMATION
Directors
Mrs KC Ball
Mr KJ Ball
Secretary
Mrs KC Ball
Company number
03921428
Registered office
188 Blackgate Lane
Tarleton
Preston
England
PR4 6UU
Auditor
Wilson Henry LLP
145 Edge Lane
Liverpool
Merseyside
United Kingdom
L7  2PF
LOVANIA NURSERIES LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Group statement of comprehensive income
7
Group balance sheet
8
Company balance sheet
9
Group statement of changes in equity
10
Company statement of changes in equity
11
Group statement of cash flows
12
Notes to the financial statements
13 - 26
LOVANIA NURSERIES LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2020
- 1 -

The directors present the strategic report for the year ended 31 December 2020.

Fair review of the business

The results of the year and the financial position of the Group and the company are shown within the annexed financial statements.

 

Turnover during the year for the Group was £17.5M compared with £17.5M in the previous year. The directors are pleased with the business performance that has been achieved during the year, given that trading was difficult, particularly in the second quarter of the year when garden centres were closed due to Covid. As in previous years the business continues to reinvest in capital equipment to improve efficiencies.

Principal risks and uncertainties

Focus on product portfolio and offerings have helped to manage the seasonality of the business. The split of sales between garden centres and retail customers is also managed to provide a balanced customer base that is expanding on both sides.

 

The ongoing challenge and principal uncertainty facing the business continues to be the weather, but the business continues to adapt and manage around this continuously. An additional risk to consider for the upcoming years is the impact the national living wage and increases to the national minimum wage will have on the cost base of the business.

 

Development and performance

The directors are confident the company is well placed to maintain its position as the leading alpine grower in the country, as well as continuing to grow the bedding plant side of the business. Future growth will also be supported by capital investment.

On behalf of the board

Mrs KC Ball
Director
31 July 2021
LOVANIA NURSERIES LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2020
- 2 -

The directors present their annual report and financial statements for the year ended 31 December 2020.

Principal activities

The principal activity of the company and group continued to be that of a horticultural grower.

Results and dividends

The results for the year are set out on page 7.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mrs KC Ball
Mr KJ Ball
Mrs CD Prout
(Resigned 31 December 2020)
Auditor

The auditor, Wilson Henry LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

LOVANIA NURSERIES LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 3 -
On behalf of the board
Mrs KC Ball
Mr KJ Ball
Director
Director
31 July 2021
LOVANIA NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF LOVANIA NURSERIES LIMITED
- 4 -
Opinion

We have audited the financial statements of Lovania Nurseries Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2020 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2020 and of the group's loss for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

LOVANIA NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF LOVANIA NURSERIES LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  • adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

  • the parent company financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of directors' remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Based on our understanding of the company and industry, we identified that there are no particular principal risks of non-compliance with laws and regulations. We also considered those laws and regulation that have direct impact on the financial statements such as the Companies Act 2006. We evaluated management’s incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls), and determined that the principal risks were related to posting inappropriate journal entries to increase profits, through management bias in manipulation of accounting for significant creditors and expenses.

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

LOVANIA NURSERIES LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF LOVANIA NURSERIES LIMITED
- 6 -

Audit procedures performed included:

 

  • Enquiry of management, those charged with governance around actual and potential litigation and claims.

  • Enquiry of entity staff in tax and compliance functions to identify any instances of non-compliance with laws and regulations.

  • Reviewing minutes of meetings of those charged with governance.

  • Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations.

  • Auditing the risk of management override of controls, including through testing journal entries and other adjustments for appropriateness, and evaluating the business rationale of significant transactions outside the normal course of business.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Hilene Henry (Senior Statutory Auditor)
For and on behalf of Wilson Henry LLP
31 July 2021
Chartered Accountants
Statutory Auditor
145 Edge Lane
Liverpool
Merseyside
United Kingdom
L7  2PF
LOVANIA NURSERIES LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2020
- 7 -
2020
2019
Notes
£
£
Turnover
2
17,536,190
17,466,538
Cost of sales
(14,236,180)
(13,630,888)
Gross profit
3,300,010
3,835,650
Administrative expenses
(3,995,826)
(3,485,549)
Other operating income
304,438
259,975
Operating (loss)/profit
4
(391,378)
610,076
Interest receivable and similar income
8
303
2,109
Interest payable and similar expenses
9
(82,743)
(87,595)
(Loss)/profit before taxation
(473,818)
524,590
Tax on (loss)/profit
10
198,007
(24,301)
(Loss)/profit for the financial year
(275,811)
500,289
(Loss)/profit for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company.
LOVANIA NURSERIES LIMITED
GROUP BALANCE SHEET
AS AT 31 DECEMBER 2020
31 December 2020
- 8 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
13
5,889,058
6,085,118
Investments
14
550,000
550,000
6,439,058
6,635,118
Current assets
Stocks
15
2,594,510
2,520,272
Debtors
16
1,621,939
1,566,218
Cash at bank and in hand
622,461
120,623
4,838,910
4,207,113
Creditors: amounts falling due within one year
17
(4,220,356)
(3,186,490)
Net current assets
618,554
1,020,623
Total assets less current liabilities
7,057,612
7,655,741
Creditors: amounts falling due after more than one year
18
(2,141,909)
(2,266,220)
Provisions for liabilities
Deferred tax liability
21
225,655
423,662
(225,655)
(423,662)
Net assets
4,690,048
4,965,859
Capital and reserves
Called up share capital
22
2
2
Profit and loss reserves
4,690,046
4,965,857
Total equity
4,690,048
4,965,859
The financial statements were approved by the board of directors and authorised for issue on 31 July 2021 and are signed on its behalf by:
31 July 2021
Mrs KC Ball
Mr KJ Ball
Director
Director
LOVANIA NURSERIES LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2020
31 December 2020
- 9 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
13
5,461,614
5,657,728
Investments
14
550,100
550,100
6,011,714
6,207,828
Current assets
Stocks
15
2,455,270
2,140,082
Debtors
16
1,959,566
1,972,667
Cash at bank and in hand
370,467
95,511
4,785,303
4,208,260
Creditors: amounts falling due within one year
17
(4,043,359)
(3,066,061)
Net current assets
741,944
1,142,199
Total assets less current liabilities
6,753,658
7,350,027
Creditors: amounts falling due after more than one year
18
(1,613,113)
(1,723,146)
Provisions for liabilities
Deferred tax liability
21
227,695
426,122
(227,695)
(426,122)
Net assets
4,912,850
5,200,759
Capital and reserves
Called up share capital
22
2
2
Profit and loss reserves
4,912,848
5,200,757
Total equity
4,912,850
5,200,759

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s loss for the year was £287,910 (2019 - £483,645 profit).

The financial statements were approved by the board of directors and authorised for issue on 31 July 2021 and are signed on its behalf by:
31 July 2021
Mrs KC Ball
Mr KJ Ball
Director
Director
Company Registration No. 03921428
LOVANIA NURSERIES LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2020
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2019
2
4,475,568
4,475,570
Year ended 31 December 2019:
Profit and total comprehensive income for the year
-
500,289
500,289
Dividends
11
-
(10,000)
(10,000)
Balance at 31 December 2019
2
4,965,857
4,965,859
Year ended 31 December 2020:
Loss and total comprehensive income for the year
-
(275,811)
(275,811)
Balance at 31 December 2020
2
4,690,046
4,690,048
LOVANIA NURSERIES LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2020
- 11 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2019
2
4,727,113
4,727,115
Year ended 31 December 2019:
Profit and total comprehensive income for the year
-
483,644
483,644
Dividends
11
-
(10,000)
(10,000)
Balance at 31 December 2019
2
5,200,757
5,200,759
Year ended 31 December 2020:
Loss and total comprehensive income for the year
-
(287,909)
(287,909)
Balance at 31 December 2020
2
4,912,848
4,912,850
LOVANIA NURSERIES LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2020
- 12 -
2020
2019
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
25
1,279,802
787,856
Interest paid
(82,743)
(87,595)
Income taxes (paid)/refunded
-
86,806
Net cash inflow from operating activities
1,197,059
787,067
Investing activities
Purchase of tangible fixed assets
(509,514)
(1,331,558)
Proceeds on disposal of tangible fixed assets
2,975
10,266
Interest received
303
2,109
Net cash used in investing activities
(506,236)
(1,319,183)
Financing activities
Repayment of borrowings
-
61,393
Proceeds of new bank loans
-
439,494
Repayment of bank loans
(139,679)
(296,947)
Payment of finance leases obligations
(49,306)
(40,900)
Dividends paid to equity shareholders
-
(10,000)
Net cash (used in)/generated from financing activities
(188,985)
153,040
Net increase/(decrease) in cash and cash equivalents
501,838
(379,076)
Cash and cash equivalents at beginning of year
120,623
499,699
Cash and cash equivalents at end of year
622,461
120,623
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020
- 13 -
1
Accounting policies
Company information

Lovania Nurseries Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is .

 

The group consists of Lovania Nurseries Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

  • Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: The disclosure requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b), 11.48(c), 12.26, 12.27, 12.29(a), 12.29(b), and 12.29A;

  • Section 26 ‘Share based Payment’: Share based payment arrangements required under FRS 102 paragraphs 26.18(b), 26.19 to 26.21 and 26.23;

  • Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

1.2
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 14 -
1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Lovania Nurseries Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 December 2020. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

1.4
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.5
Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

1.6
Intangible fixed assets - goodwill

Goodwill, being the excess of the amount paid in consideration over the net assets of the business acquired in 2015, is now fully written off.

1.7
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
over the life of the asset
Leasehold improvements
over the life of the asset
Plant and equipment
over the life of the asset
Fixtures and fittings
over the life of the asset
Computers
over the life of the asset
Motor vehicles
over the life of the asset

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 15 -
1.8
Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

1.11
Leases

Assets obtained under finance leases are capitalised in the balance sheet and are deprecated over their estimated useful lives or the lease term, whichever is shorter.

 

The interest element of these obligations is charged to the profit and loss account over the relevant period. The capital element is treated as a liability.

1.12
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 16 -
1.13
Foreign exchange

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

2
Turnover and other revenue
2020
2019
£
£
Other significant revenue
Interest income
303
2,109
Grants received
91,721
-
3
Exceptional item
2020
2019
£
£
Expenditure
Exceptional items
15,656
(224,291)
4
Operating (loss)/profit
2020
2019
£
£
Operating (loss)/profit for the year is stated after charging/(crediting):
Exchange differences apart from those arising on financial instruments measured at fair value through profit or loss
16,927
3,021
Government grants
(91,721)
-
Depreciation of owned tangible fixed assets
756,238
660,441
Profit on disposal of tangible fixed assets
(2,975)
(8,268)
5
Auditor's remuneration
2020
2019
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
9,000
9,000
Audit of the financial statements of the company's subsidiaries
6,500
6,500
15,500
15,500
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 17 -
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2020
2019
2020
2019
Number
Number
Number
Number
Employees
127
116
113
102
Directors
3
3
3
3
Total
130
119
116
105

Their aggregate remuneration comprised:

Group
Company
2020
2019
2020
2019
£
£
£
£
Wages and salaries
3,315,729
2,906,117
3,031,690
2,630,714
Social security costs
16,293
22,749
10,647
16,059
Pension costs
68,983
60,287
65,480
61,164
3,401,005
2,989,153
3,107,817
2,707,937
7
Directors' remuneration
2020
2019
£
£
Remuneration for qualifying services
94,636
136,663
Company pension contributions to defined contribution schemes
1,014
3,659
95,650
140,322
8
Interest receivable and similar income
2020
2019
£
£
Interest income
Interest on bank deposits
303
2,109
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 18 -
9
Interest payable and similar expenses
2020
2019
£
£
Interest on bank overdrafts and loans
6,369
27,621
Other interest on financial liabilities
61,237
50,512
Interest on finance leases and hire purchase contracts
15,137
9,462
Total finance costs
82,743
87,595
10
Taxation
2020
2019
£
£
Current tax
Adjustments in respect of prior periods
-
(122,364)
Deferred tax
Origination and reversal of timing differences
(198,007)
146,665
Total tax (credit)/charge
(198,007)
24,301

The actual (credit)/charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:

2020
2019
£
£
(Loss)/profit before taxation
(473,818)
524,590
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 19.00% (2019: 19.00%)
(90,025)
99,672
Tax effect of expenses that are not deductible in determining taxable profit
26,102
48,485
Tax effect of utilisation of tax losses not previously recognised
-
(3,313)
Unutilised tax losses carried forward
79,669
-
Adjustments in respect of prior years
-
(122,364)
Permanent capital allowances in excess of depreciation
(15,746)
(142,047)
Other permanent differences
(198,007)
143,868
Taxation (credit)/charge
(198,007)
24,301
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 19 -
11
Dividends
2020
2019
Recognised as distributions to equity holders:
£
£
Final paid
-
10,000
12
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 January 2020 and 31 December 2020
299,995
Amortisation and impairment
At 1 January 2020 and 31 December 2020
299,995
Carrying amount
At 31 December 2020
-
At 31 December 2019
-
The company had no intangible fixed assets at 31 December 2020 or 31 December 2019.
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 20 -
13
Tangible fixed assets
Group
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
£
£
Cost
At 1 January 2020
2,518,020
295,817
6,407,693
58,461
18,272
173,152
9,471,415
Additions
250,733
9,530
209,270
7,937
36,698
46,010
560,178
Disposals
-
-
-
-
-
(19,547)
(19,547)
At 31 December 2020
2,768,753
305,347
6,616,963
66,398
54,970
199,615
10,012,046
Depreciation and impairment
At 1 January 2020
195,645
166,808
2,863,297
33,209
10,915
116,423
3,386,297
Depreciation charged in the year
45,064
25,423
631,177
9,476
12,832
32,266
756,238
Eliminated in respect of disposals
-
-
-
-
-
(19,547)
(19,547)
At 31 December 2020
240,709
192,231
3,494,474
42,685
23,747
129,142
4,122,988
Carrying amount
At 31 December 2020
2,528,044
113,116
3,122,489
23,713
31,223
70,473
5,889,058
At 31 December 2019
2,322,375
129,009
3,544,396
25,252
7,357
56,729
6,085,118
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
13
Tangible fixed assets
(Continued)
- 21 -
Company
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
£
£
Cost
At 1 January 2020
2,068,020
291,617
6,355,830
58,461
15,492
171,147
8,960,567
Additions
240,482
9,530
207,934
7,937
36,298
39,760
541,941
Disposals
-
0
-
0
-
0
-
0
-
0
(17,542)
(17,542)
At 31 December 2020
2,308,502
301,147
6,563,764
66,398
51,790
193,365
9,484,966
Depreciation and impairment
At 1 January 2020
159,645
164,218
2,822,454
33,209
8,895
114,418
3,302,839
Depreciation charged in the year
35,210
24,583
624,959
9,476
12,082
31,745
738,055
Eliminated in respect of disposals
-
0
-
0
-
0
-
0
-
0
(17,542)
(17,542)
At 31 December 2020
194,855
188,801
3,447,413
42,685
20,977
128,621
4,023,352
Carrying amount
At 31 December 2020
2,113,647
112,346
3,116,351
23,713
30,813
64,744
5,461,614
At 31 December 2019
1,908,375
127,399
3,533,376
25,252
6,597
56,729
5,657,728
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 22 -
14
Fixed asset investments
Group
Company
2020
2019
2020
2019
£
£
£
£
Unlisted investments
550,000
550,000
550,100
550,100
Movements in fixed asset investments
Group
Investments
£
Cost or valuation
At 1 January 2020 and 31 December 2020
550,000
Carrying amount
At 31 December 2020
550,000
At 31 December 2019
550,000
Movements in fixed asset investments
Company
Investments
£
Cost or valuation
At 1 January 2020 and 31 December 2020
550,100
Carrying amount
At 31 December 2020
550,100
At 31 December 2019
550,100
15
Stocks
Group
Company
2020
2019
2020
2019
£
£
£
£
Finished goods and goods for resale
2,594,510
2,520,272
2,455,270
2,140,082
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 23 -
16
Debtors
Group
Company
2020
2019
2020
2019
Amounts falling due within one year:
£
£
£
£
Trade debtors
1,222,327
1,212,415
1,186,692
1,187,303
Amounts owed by group undertakings
-
-
386,392
421,024
Other debtors
222,422
206,063
222,422
230,267
Prepayments and accrued income
177,190
147,740
164,060
134,073
1,621,939
1,566,218
1,959,566
1,972,667
17
Creditors: amounts falling due within one year
Group
Company
2020
2019
2020
2019
Notes
£
£
£
£
Bank loans
19
214,615
220,757
184,793
190,935
Obligations under finance leases
20
28,065
35,933
27,482
32,645
Trade creditors
3,141,176
2,309,012
3,108,807
2,267,456
Other taxation and social security
81,171
53,433
63,476
49,575
Other creditors
356,939
284,023
316,388
280,905
Accruals and deferred income
398,390
283,332
342,413
244,545
4,220,356
3,186,490
4,043,359
3,066,061
18
Creditors: amounts falling due after more than one year
Group
Company
2020
2019
2020
2019
Notes
£
£
£
£
Bank loans and overdrafts
19
2,113,410
2,246,947
1,584,614
1,703,873
Obligations under finance leases
20
28,499
19,273
28,499
19,273
2,141,909
2,266,220
1,613,113
1,723,146
Amounts included above which fall due after five years are as follows:
Payable by instalments
586,759
704,840
586,759
704,840
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 24 -
19
Loans and overdrafts
Group
Company
2020
2019
2020
2019
£
£
£
£
Bank loans
2,328,025
2,467,704
1,769,407
1,894,808
Payable within one year
214,615
220,757
184,793
190,935
Payable after one year
2,113,410
2,246,947
1,584,614
1,703,873
20
Finance lease obligations
Group
Company
2020
2019
2020
2019
£
£
£
£
Future minimum lease payments due under finance leases:
Within one year
19,856
35,933
19,273
32,645
In two to five years
36,708
19,273
36,708
19,273
56,564
55,206
55,981
51,918
21
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
2020
2019
Group
£
£
Accelerated capital allowances
225,655
423,662
Liabilities
Liabilities
2020
2019
Company
£
£
Accelerated capital allowances
227,695
426,122
LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
21
Deferred taxation
(Continued)
- 25 -
Group
Company
2020
2020
Movements in the year:
£
£
Liability at 1 January 2020
423,662
426,122
Credit to profit or loss
(198,007)
(198,427)
Liability at 31 December 2020
225,655
227,695
22
Share capital
2020
2019
2020
2019
Ordinary share capital
Number
Number
£
£
Issued and fully paid
of £1 each
2
2
2
2
23
Operating lease commitments

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2020
2019
2020
2019
£
£
£
£
Within one year
156,296
140,134
77,955
68,910
Between two and five years
262,224
339,654
131,112
169,634
418,520
479,788
209,067
238,544
24
Events after the reporting date

The COVID-19 pandemic has continued to develop in 2021, with significant numbers of cases still being reported. Measures taken by various governments to contain the virus have affected economic activity. We have taken a number of measures to monitor and mitigate the effects of COVID-19, such as health and safety measures for our people (such as social distancing and working from home if possible) and securing the supply of materials that are essential to our production process. At this stage, the impact on our business and results has not been significant and based on our experience to date we expect this to remain the case. We will continue to follow the various government policies and advice and, in parallel, we will do our utmost to continue our operations in the best and safest way possible, without jeopardising the health of our people.

LOVANIA NURSERIES LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 26 -
25
Cash generated from group operations
2020
2019
£
£
(Loss)/profit for the year after tax
(275,811)
500,289
Adjustments for:
Taxation (credited)/charged
(198,007)
24,301
Finance costs
82,743
87,595
Investment income
(303)
(2,109)
Gain on disposal of tangible fixed assets
(2,975)
(8,268)
Depreciation and impairment of tangible fixed assets
756,238
660,441
Movements in working capital:
Increase in stocks
(74,238)
(677,862)
(Increase)/decrease in debtors
(55,721)
1,061,616
Increase/(decrease) in creditors
1,047,876
(858,147)
Cash generated from operations
1,279,802
787,856
26
Analysis of changes in net debt - group
1 January 2020
Cash flows
New finance leases
31 December 2020
£
£
£
£
Cash at bank and in hand
120,623
501,838
-
622,461
Borrowings excluding overdrafts
(2,467,704)
139,679
-
(2,328,025)
Obligations under finance leases
(55,206)
49,306
(50,664)
(56,564)
(2,402,287)
690,823
(50,664)
(1,762,128)
2020-12-312020-01-01falseCCH SoftwareCCH Accounts Production 2021.200Mr KJ BallMrs CD ProutMs C D ProutMrs KC Ball039214282020-01-012020-12-3103921428bus:CompanySecretaryDirector12020-01-012020-12-3103921428bus:Director12020-01-012020-12-3103921428bus:CompanySecretary12020-01-012020-12-3103921428bus:Director22020-01-012020-12-3103921428bus:Director32020-01-012020-12-3103921428bus:RegisteredOffice2020-01-012020-12-3103921428bus:Consolidated2020-12-31039214282020-12-31039214282019-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2020-12-3103921428core:LeaseholdImprovements2020-12-3103921428core:PlantMachinery2020-12-3103921428core:FurnitureFittings2020-12-3103921428core:ComputerEquipment2020-12-3103921428core:MotorVehicles2020-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2019-12-3103921428core:LeaseholdImprovements2019-12-3103921428core:PlantMachinery2019-12-3103921428core:FurnitureFittings2019-12-3103921428core:ComputerEquipment2019-12-3103921428core:MotorVehicles2019-12-3103921428core:ShareCapital2020-12-3103921428core:ShareCapital2019-12-31039214282019-01-012019-12-3103921428core:Goodwill2020-01-012020-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2020-01-012020-12-3103921428core:LeaseholdImprovements2020-01-012020-12-3103921428core:PlantMachinery2020-01-012020-12-3103921428core:FurnitureFittings2020-01-012020-12-3103921428core:ComputerEquipment2020-01-012020-12-3103921428core:MotorVehicles2020-01-012020-12-3103921428core:LandBuildingscore:OwnedOrFreeholdAssets2019-12-3103921428core:LeaseholdImprovements2019-12-3103921428core:PlantMachinery2019-12-3103921428core:FurnitureFittings2019-12-3103921428core:ComputerEquipment2019-12-3103921428core:MotorVehicles2019-12-31039214282019-12-3103921428core:UnlistedNon-exchangeTraded2020-12-3103921428core:UnlistedNon-exchangeTraded2019-12-3103921428core:CurrentFinancialInstruments2020-12-3103921428core:CurrentFinancialInstruments2019-12-3103921428core:Non-currentFinancialInstruments2020-12-3103921428core:Non-currentFinancialInstruments2019-12-3103921428core:WithinOneYear2020-12-3103921428core:WithinOneYear2019-12-3103921428core:BetweenTwoFiveYears2020-12-3103921428core:BetweenTwoFiveYears2019-12-3103921428bus:PrivateLimitedCompanyLtd2020-01-012020-12-3103921428bus:FRS1022020-01-012020-12-3103921428bus:Audited2020-01-012020-12-3103921428bus:ConsolidatedGroupCompanyAccounts2020-01-012020-12-3103921428bus:FullAccounts2020-01-012020-12-31xbrli:purexbrli:sharesiso4217:GBP